During the last session, Taysha Gene Therapies Inc (NASDAQ:TSHA)’s traded shares were 5.03 million, with the beta value of the company hitting 0.46. At the
In the last trading session, 7.29 million shares of the Taysha Gene Therapies Inc (NASDAQ:TSHA) were traded, and its beta was 0.50. Most recently the
Taysha Gene Therapies Inc (NASDAQ:TSHA)’s traded shares stood at 10.3 million during the last session, with the company’s beta value hitting 0.50. At the close
Taysha Gene Therapies Inc (NASDAQ:TSHA)’s traded shares stood at 6.72 million during the last session, with the company’s beta value hitting 0.54. At the close
In the latest trading session, 0.41 million Taysha Gene Therapies Inc (NASDAQ:TSHA) shares changed hands as the company’s beta touched 0.36. With the company’s most
In last trading session, Taysha Gene Therapies Inc (NASDAQ:TSHA) saw 4.49 million shares changing hands with its beta currently measuring 0.36. Company’s recent per share
Taysha Gene Therapies Inc (NASDAQ:TSHA) has a beta value of 0.44 and has seen 12.99 million shares traded in the last trading session. The company,
Taysha Gene Therapies Inc (NASDAQ:TSHA) has a beta value of 0.42 and has seen 7.45 million shares traded in the last trading session. The company,
In the latest trading session, 1.03 million Taysha Gene Therapies Inc (NASDAQ:TSHA) shares changed hands as the company’s beta touched 0.38. With the company’s most
During the last session, Taysha Gene Therapies Inc (NASDAQ:TSHA)’s traded shares were 1.36 million, with the beta value of the company hitting 0.38. At the
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
